Добро пожаловать
Нажатие «Авторизоваться» означает, что вы соглашаетесь с Условия использования и политика конфиденциальности Cointime.
Зарегистрировать аккаунт
Аккаунт уже существует?
Нажатие «page.Sign up» означает, что вы соглашаетесь с <a class="underline" href="#term-of-service">Условия использования</a> и a class="underline" href="#privacy-policy">политика конфиденциальности</a> Cointime.
Войдите, используя email
Зарегистрируйтесь с помощью email
твой почтовый ящик
Проверь свои входящие
Нажмите на ссылку в , чтобы войти.
Нажмите на ссылку в , чтобы зарегистрироваться.
Sumatra Biorenewables, LLC
company
About
Biobased monomer producer for use in the production of nylon.
- 1 - 10
Details
- Last Funding Type
- Grant
- Last Funding Money Raised
- $225K
- Industries
- Biotechnology,Chemical
- Founded date
- Oct 15, 2015
- Number Of Employee
- 1 - 10
- Operating Status
- Active
Sumatra Biorenewables, LLC is a startup that specializes in the production of trans‐3‐hexenedioic acid (3HDA), a novel biobased monomer manufactured from biologically‐produced muconic acid (MA). The introduction of 3HDA in polyamides or polyesters through copolymerization or compounding provides an ethylenic bond that enables the production of materials with tailored functional properties without altering the intrinsic nature of the polymeric material.
Funding Rounds
Number of Funding Rounds
Total Funding Amount
1
$225K
Sumatra Biorenewables, LLC has raised a total of
$225K
in funding over 2 rounds. Their latest funding was raised on
Jun 25, 2018 from a Grant round.
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| Jun 25, 2018 | Grant | $225K | 1 |
National Science Foundation
|
— | Detail |
Investors
Number of Lead Investors
Number of Investors
1
1
Sumatra Biorenewables, LLC is funded by 1 investors.
National Science Foundation
are the most recent investors.
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
|
National Science Foundation
|
Yes | Grant |
Share
Twitter
LinkedIn
Line
Facebook
Telegram
Email
Page Link
